ATE537142T1 - Übergangsmetallkatalysierte synthese von n- aminoindolen - Google Patents

Übergangsmetallkatalysierte synthese von n- aminoindolen

Info

Publication number
ATE537142T1
ATE537142T1 AT08734883T AT08734883T ATE537142T1 AT E537142 T1 ATE537142 T1 AT E537142T1 AT 08734883 T AT08734883 T AT 08734883T AT 08734883 T AT08734883 T AT 08734883T AT E537142 T1 ATE537142 T1 AT E537142T1
Authority
AT
Austria
Prior art keywords
transition metal
metal catalyzed
aminoindoles
formula
catalyzed synthesis
Prior art date
Application number
AT08734883T
Other languages
English (en)
Inventor
Nis Halland
M Nazare
Andreas Lindenschmidt
Omar Rkyek
Matthias Urmann
Jorge Alonso
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE537142T1 publication Critical patent/ATE537142T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT08734883T 2007-04-13 2008-03-29 Übergangsmetallkatalysierte synthese von n- aminoindolen ATE537142T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07007585 2007-04-13
PCT/EP2008/002519 WO2008125207A1 (en) 2007-04-13 2008-03-29 A transition metal catalyzed synthesis of n-aminoindoles

Publications (1)

Publication Number Publication Date
ATE537142T1 true ATE537142T1 (de) 2011-12-15

Family

ID=38457866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08734883T ATE537142T1 (de) 2007-04-13 2008-03-29 Übergangsmetallkatalysierte synthese von n- aminoindolen

Country Status (12)

Country Link
US (1) US8026375B2 (de)
EP (1) EP2134682B1 (de)
JP (1) JP5412422B2 (de)
KR (1) KR20100015546A (de)
CN (1) CN101657422A (de)
AT (1) ATE537142T1 (de)
AU (1) AU2008238379A1 (de)
BR (1) BRPI0810199A2 (de)
CA (1) CA2683578A1 (de)
IL (1) IL201253A0 (de)
MX (1) MX2009010536A (de)
WO (1) WO2008125207A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006068760A2 (en) 2004-11-19 2006-06-29 The Regents Of The University Of California Anti-inflammatory pyrazolopyrimidines
CA2909277A1 (en) 2006-04-04 2007-10-11 Kevan M. Shokat Kinase antagonists
WO2009046448A1 (en) 2007-10-04 2009-04-09 Intellikine, Inc. Chemical entities and therapeutic uses thereof
DK2240451T3 (da) 2008-01-04 2017-11-20 Intellikine Llc Isoquinolinonderivater substitueret med en purin, der er anvendelig som pi3k-inhibitorer
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
EP2252293B1 (de) 2008-03-14 2018-06-27 Intellikine, LLC Kinasehemmer und verwendungsverfahren
WO2009114874A2 (en) 2008-03-14 2009-09-17 Intellikine, Inc. Benzothiazole kinase inhibitors and methods of use
US20110224223A1 (en) 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof
US9096611B2 (en) 2008-07-08 2015-08-04 Intellikine Llc Kinase inhibitors and methods of use
WO2010036380A1 (en) 2008-09-26 2010-04-01 Intellikine, Inc. Heterocyclic kinase inhibitors
US8697709B2 (en) 2008-10-16 2014-04-15 The Regents Of The University Of California Fused ring heteroaryl kinase inhibitors
US8476431B2 (en) 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
EP2427195B1 (de) 2009-05-07 2019-05-01 Intellikine, LLC Heterocyclische verbindungen und ihre verwendung
WO2011047384A2 (en) 2009-10-16 2011-04-21 The Regents Of The University Of California Methods of inhibiting ire1
EP2571357B1 (de) 2010-05-21 2016-07-06 Infinity Pharmaceuticals, Inc. Chemische verbindungen, zusammensetzungen und verfahren zur kinasemodulation
WO2012064973A2 (en) 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
DK2663309T3 (en) 2011-01-10 2017-06-19 Infinity Pharmaceuticals Inc METHODS FOR PRODUCING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
CN102093334B (zh) * 2011-02-22 2013-05-08 郑州大学 一组稠环噻吩类化合物的合成方法
EP2678018A4 (de) 2011-02-23 2015-09-30 Intellikine Llc Kombination von kinasehemmern und verwendungen dafür
KR20140063605A (ko) 2011-07-19 2014-05-27 인피니티 파마슈티칼스, 인코포레이티드 헤테로사이클릭 화합물 및 그의 용도
US8969363B2 (en) 2011-07-19 2015-03-03 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
AR091790A1 (es) 2011-08-29 2015-03-04 Infinity Pharmaceuticals Inc Derivados de isoquinolin-1-ona y sus usos
MX370814B (es) 2011-09-02 2020-01-08 Univ California Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
AU2013323426A1 (en) 2012-09-26 2015-04-23 The Regents Of The University Of California Modulation of ire1
KR102229478B1 (ko) 2012-11-01 2021-03-18 인피니티 파마슈티칼스, 인코포레이티드 Pi3 키나아제 동형단백질 조절인자를 사용하는 암의 치료
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
PL3052485T3 (pl) 2013-10-04 2022-02-28 Infinity Pharmaceuticals, Inc. Związki heterocykliczne i ich zastosowania
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN103755621B (zh) * 2014-01-23 2015-08-05 清华大学 由芳基肼和炔烃制备多取代吲哚的方法
CA2943075C (en) 2014-03-19 2023-02-28 Infinity Pharmaceuticals, Inc. Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
US20150320755A1 (en) 2014-04-16 2015-11-12 Infinity Pharmaceuticals, Inc. Combination therapies
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2016069796A1 (en) * 2014-10-28 2016-05-06 Spectrum Spine Ip Holdings, Llc Expandable, adjustable inter-body fusion devices and methods
NZ740616A (en) 2015-09-14 2023-05-26 Infinity Pharmaceuticals Inc Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
IL263680B2 (en) 2016-06-24 2025-10-01 Infinity Pharmaceuticals Inc PI3K inhibitors for use in combination with a second therapeutic agent for the treatment, management or prevention of cancer
KR102038977B1 (ko) * 2016-12-30 2019-11-01 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 신규한 시클로펜타[b]티오펜일 전이금속 화합물, 이를 포함하는 전이금속 촉매 조성물, 및 이를 이용한 에틸렌 단독중합체 또는 에틸렌과 α-올레핀의 공중합체의 제조방법
CN113874015B (zh) 2018-12-21 2024-05-24 细胞基因公司 Ripk2的噻吩并吡啶抑制剂
CN121021734A (zh) * 2018-12-21 2025-11-28 陶氏环球技术有限责任公司 用于烯烃聚合的基于杂环-杂环的iv族过渡金属催化剂
CN116813522A (zh) * 2023-05-04 2023-09-29 广州方中化工有限公司 一种含吲哚的苯磺酰脲类化合物的制备方法与应用
CN118638038B (zh) * 2024-06-05 2024-12-03 常州大学 一种n-n轴手性吲哚酰胺类化合物及其合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065324T3 (es) * 1987-04-24 1995-02-16 Hoechst Roussel Pharma N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
US4983608A (en) 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
EP1035114B1 (de) 1999-03-10 2004-11-24 Tosoh Corporation Verfahren zur Herstellung Stickstoffheterocyclischer Verbindungen
FR2842196B1 (fr) * 2002-07-15 2006-01-13 Rhodia Polyamide Intermediates Procede de fabrication de composes nitriles a partir de composes a insaturation ethylenique
EP1732612B1 (de) 2004-04-08 2009-09-16 Jado Technologies GmbH Dreigeteilte konjugate mit einer struktur, die mit zellmembran-rafts interagieren und ihre verwendung

Also Published As

Publication number Publication date
US8026375B2 (en) 2011-09-27
BRPI0810199A2 (pt) 2014-10-14
IL201253A0 (en) 2010-05-31
EP2134682A1 (de) 2009-12-23
JP2010523605A (ja) 2010-07-15
AU2008238379A1 (en) 2008-10-23
CA2683578A1 (en) 2008-10-23
CN101657422A (zh) 2010-02-24
MX2009010536A (es) 2009-10-22
JP5412422B2 (ja) 2014-02-12
KR20100015546A (ko) 2010-02-12
US20100168429A1 (en) 2010-07-01
EP2134682B1 (de) 2011-12-14
WO2008125207A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
ATE537142T1 (de) Übergangsmetallkatalysierte synthese von n- aminoindolen
MX2009013753A (es) Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles.
MX2009014203A (es) Una sintesis de 2h-indazoles catalizada por un metal de transicion.
ATE544757T1 (de) Regioselektive, palladiumkatalysierte synthese von benzimidazolen und azabenzimidazolen
MY150379A (en) Fused heterocyclic derivative and use thereof
TNSN08372A1 (en) Heterocyclic amides for use as pharmaceuticals
TW200732335A (en) Organic compounds
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
MX2009008772A (es) Derivado piridil-triazolopirimidina o su sal, pesticida que lo contiene y proceso para su produccion.
TW200635921A (en) Organic compounds
MX2009013738A (es) Un procedimiento catalizado por paladio para el acoplamiento de alquinos terminales con tosilatos de arilo.
GB0508318D0 (en) Organic compounds
TW200638930A (en) Acetylene derivatives
TW200732337A (en) Organic compounds
WO2008156102A1 (ja) ピラゾロン誘導体及びそれらを有効成分とするpde阻害剤
TW200744996A (en) Improved process for the production of nitroisourea derivative
ATE550326T1 (de) Als modulatoren von hdl einsetzbare verbindungen
MY151461A (en) A process for the palladium-catalyzed coupling of terminal alkynes with heteroayl tosylates and heteroaryl benzenesulfonates
TW200716521A (en) Substituted aryl oximes
FR2977253B1 (fr) Reactif organostannique alcoxyle supporte, preparation et utilisation pour la synthese de tetrazoles en phase heterogene
MX2007007554A (es) Oxiarenos sustituidos.
TW200621693A (en) Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as synthetic intermediates
TH104280A (th) กรรมวิธีสำหรับการเตรียมอนุพันธ์เบนโซ-ฟิวส์เฮเทอโรแอริล
WO2008125295A3 (de) Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln
WO2013186624A3 (ko) α, β- 치환 카르보닐 화합물, 이로부터 유도된 광학 활성 헤테로고리 화합물, 및 그 합성방법.